ARQT
NASDAQ · Biotechnology
Arcutis Biotherapeutics Inc
$25.96
+0.58 (+2.29%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+49.41%
YTD
-10.48%
Open$25.57
Previous Close$25.38
Day High$26.08
Day Low$25.19
52W High$31.77
52W Low$16.57
Volume—
Avg Volume3.00M
Market Cap3.33B
P/E Ratio116.62
EPS$0.21
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$27.64
Below
SMA 200
$20.38
Above
RSI (14)
67.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
+230.4% upside
Current
$25.96
$25.96
Target
$85.78
$85.78
$74.20
$85.78 avg
$112.10
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 387.33M | 947.52M | 972.47M |
| Net Income | -16,629,046 | 179.95M | 161.28M |
| Profit Margin | -4.3% | 19.0% | 16.6% |
| EBITDA | -12,592,997 | 271.10M | 315.26M |
| Free Cash Flow | — | 104.36M | 84.89M |
| Rev Growth | +367.1% | -4.3% | +9.4% |
| Debt/Equity | 0.58 | 0.78 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |